SEC Form 4/A · accession 0001493152-18-010543
Provention Bio, Inc. · PRVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Cameron Gray
Director
Period of report
Jul 19, 2018
Accepted (ET)
Jul 26, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001695357
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $5.00 | Jul 19, 2018 | J | 504,668 | A | Jun 28, 2019 | Jul 3, 2023 | Common Stock, par value $0.0001 | 504,668 | 504,668 | D |
Explanation of responses
- F1Upon closing of the initial public offering of Provention Bio, Inc., a warrant was issued to MDB Capital Group LLC as partial consideration for services related to the offering. MDB Capital Group assigned a portion of that warrant to reporting person effective July 19, 2018.